|
December 1, 2005
Angiotech completes acquisition of Lifespan® vascular graft product line from Edwards Lifesciences
December 12, 2005
AnorMED announces 73% of cancer patients who failed prior chemotherapy mobilizations succeed in collecting enough stem cells for transplant
December 8, 2005
AnorMED Closes $34,500,000 Bought Deal Financing
November 29, 2005
AnorMED Announces Enrollment of HIV Patients into XACT Study for AMD070 a First in Class CXCR4 HIV Entry Inhibitor
December 9, 2005
Cardiome Initiates Phase 2a Study for Oral RSD1235
December 1, 2005
CB Richard Ellis Limited has a sublease opportunity of office and lab space (3,903 square feet) at 604 West Broadway
December 2, 2005
Forbes Medi-Tech Initiates Dosing Phase in Clinical Trial for Cholesterol-Lowering Drug, FM-VP4
November 30, 2005
iCo Therapeutics Announces Strategic Advisory Team
December 8, 2005
ID Biomedical announces closing of acquisition by GlaxoSmithKline
November 23, 2005
Inflazyme Pharmaceuticals Names John Hodgman as Chairman of Board of Directors
December 8, 2005
MIGENIX Completes License Agreement for MX-594AN - Establishes Broad Dermatology Alliance with Cutanea Life Sciences, Inc.
December 6, 2005
Protox named to TSX Venture 50 list of top emerging companies
November 29, 2005
Protox releases Q3, 2005 Financials
November 24, 2005
Protox appoints Dr. James Miller to Board of Directors
December 7, 2005
QLT Announces Repositioning and Streamlining for Future Growth |
